This is a fact sheet outlining the fast facts of HIV and anal sex. This fact sheet describes the act of anal sex and why it's the riskiest sexual behavior for getting and transmitting HIV for men and women. This fact sheet also gives tips on how to reduce the risk of transmitting HIV when engaging in anal sex.
This brochure offers guidance for healthcare providers to facilitate effective conversations about sexual health with men who have sex with men patients. Topics include stigma, sexual history taking, tailored screenings for HIV and STDs, post exposure prophylaxis, and pre-exposure prophylaxis.
This Funding Opportunity Announcement (FOA) invites applications for Planning Grants (R34) that will strengthen the HIV oral pre-exposure prophylaxis (PrEP) care continuum by developing and pilot testing interventions to improve PrEP care engagement and retention among individuals at substantial risk for HIV infection, as well as interventions to support PrEP medication adherence and persistence as indicated.
This initiative will support research projects that implement and test comprehensive service approaches to engage and retain youth and young adults (age 12 25 years) from health disparity populations in the HIV Treatment Cascade, which includes diagnosis, linkage to care, engagement in care, retention in care, initiation of antiretroviral therapy (ART), and achievement of viral suppression.
The Centers for Disease Control and Prevention announces the availability of fiscal year 2016 funds for a cooperative agreement program for community-based organizations (CBOs) to develop and implement High-Impact Human Immunodeficiency Virus (HIV) Prevention Programs in the following two categories: Category A: HIV prevention services for high risk Young Men of Color Who Have Sex with Men and their partners regardless of age, gender, and race/ethnicity.
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to use innovative technology to conduct epidemiologic studies of large cohorts of U.S. populations at high risk of HIV infection: men who have sex with men (MSM), transgender women, and black/African American women. The UG3/UH3 Phased Innovation Awards Cooperative Agreement involves 2 phases. Funding for a UG3 phase will be used to enroll and follow sufficient numbers of high-risk HIV-negative participants to reach seroconversion milestone targets.
The purpose of this FOA is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country.
This project will support an evaluation of up to two locally-developed or adapted and potentially effective but insufficiently evaluated, interventions that are designed to deliver a combination of HIV prevention, HIV care and treatment, and other social and structural support services to transgender persons who have sex with men who are at risk for HIV infection or who are living with HIV.
The purpose of this funding opportunity is to evaluate the effects of an intervention that provides in-person assistance with health insurance or Medicaid enrollment following HIV testing on insurance uptake and coverage, linkage and retention rates (for HIV-positive men), and other health outcomes among Black men who have sex with men (MSM).